Literature DB >> 5638559

The combined use of alpha-methyltyrosine and threo-dihydroxyphenylserine--selective reduction of dopamine levels in the central nervous system.

C R Creveling, J Daly, T Tokuyama, B Witkop.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5638559     DOI: 10.1016/0006-2952(68)90158-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  15 in total

Review 1.  Amine precursor amino acid therapy: from neurochemical basis to clinical aspects.

Authors:  T Nakajima
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

2.  Reversal of the reserpine-induced ptosis by L-threo-3,4-dihydroxy-phenylserine (L-threo-DOPS), a (-)-norepinephrine precursor, and its potentiation by imipramine or nialamide.

Authors:  T Kato; M Katsuyama; N Karai; A Hirose; M Nakamura; J Katsube
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-03       Impact factor: 3.000

3.  Antagonism by DL-threo-DOPS of the suppression of a conditioned avoidance response induced by a dopamine-beta-hydroxylase inhibitor.

Authors:  S Ahlenius; J Engel
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

4.  Formation of noradrenaline in the rat brain from the four stereoisomers of 3,4-dihydroxyphenylserine.

Authors:  M Puig; G Bartholini; A Pletscher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  On the role of central noradrenaline in the regulation of motor activity and body temperature in the mouse.

Authors:  T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

6.  Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments.

Authors:  B R Cooper; L D Grant; G R Breese
Journal:  Psychopharmacologia       Date:  1973-07-17

7.  Threo-3,4-dihydroxyphenylserine, a poor source of noradrenaline in the rat.

Authors:  B L Goodwin; R D Johnson; B G Leask; C R Ruthven; M Sandler
Journal:  Experientia       Date:  1972-11-15

8.  Reversal of ethanol intoxications in humans: an assessment of the efficacy of propranolol.

Authors:  R L Alkana; E S Parker; H B Cohen; H Birch; E P Noble
Journal:  Psychopharmacology (Berl)       Date:  1976-12-21       Impact factor: 4.530

9.  Shy-Drager syndrome. Effect of fludrocortisone and L-threo-3,4-dihydroxyphenylserine on the blood pressure and regional cerebral blood flow.

Authors:  S Matsubara; Y Sawa; H Yokoji; M Takamori
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-11       Impact factor: 10.154

10.  Memory effect of DL-threo-3,4-dihydroxyphenylserine (DOPS) in human Korsakoff's disease.

Authors:  P J Langlais; R G Mair; P J Whalen; W McCourt; W J McEntee
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.